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Background
The dengue is a viral disease transmitted by a mosquito
from the Culicidae family from Africa, the Aedes
aegypti. Most common in tropical and subtropical
regions, this mosquito has diurnal activity and is difficult
to control due to the high resistance of its eggs and its
quick transformation into larvae. The severe illness may
cause death, most commonly presenting symptoms such
as high fever, pain behind the eyes and headaches.
Methods
Fifteen larvae (L4) were exposed in a 6.5 mg/mL concen-
tration of A.sisalana juice, during the periods of 3, 6, 12
and 24 hours, completing 4 experimental groups and one
control group for each, with means, 4 control groups.
Results and conclusions
The A. sisalana had a cytotoxic necrotizing effect on A.
aegypti hemocytes, showing that after 12 hours of exposi-
tion the larvae in juice had a 21% hemocytes mortality
compared with the control group. After 24 hours, a cell
mortality of 16.5% in relation with the control group, as
well the growth of hemocytes’ size and granularity, being
compatible with the noted necrosis. In fact, this effect was
acute, because, after 24 hours, the majority of larvae were
dead even when a sub-lethal concentration was used, what
suggest that this is the major sisal juice action mechanism.
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